68 related articles for article (PubMed ID: 1361842)
1. Could CAPD modulate the hemodynamic changes induced by rHuEPO treatment?
Fernández A; Vega N; Hortal L; Jimenez F; Laraudogoitía E; Macía M; Plaza C; Perdomo M; Palop L
Adv Perit Dial; 1992; 8():435-9. PubMed ID: 1361842
[TBL] [Abstract][Full Text] [Related]
2. Effect of recombinant human erythropoietin treatment on hemodynamic parameters in continuous ambulatory peritoneal dialysis and hemodialysis patients.
Fernández A; Vega N; Jiménez F; Macía M; Laraudiogoitía E; Hortal L; Perdomo M; Plaza C; Rodríguez JC; Palop L
Am J Nephrol; 1992; 12(4):207-11. PubMed ID: 1481867
[TBL] [Abstract][Full Text] [Related]
3. Echocardiographic findings in hemodialysis patients treated with recombinant human erythropoietin: proposal for a hematocrit most beneficial to hemodynamics.
Tagawa H; Nagano M; Saito H; Umezu M; Yamakado M
Clin Nephrol; 1991 Jan; 35(1):35-8. PubMed ID: 2007294
[TBL] [Abstract][Full Text] [Related]
4. Renormalization of high cardiac output and of left ventricular size following long-term recombinant human erythropoietin treatment of anemic dialyzed uremic patients.
Cannella G; La Canna G; Sandrini M; Gaggiotti M; Nordio G; Movilli E; Maiorca R
Clin Nephrol; 1990 Dec; 34(6):272-8. PubMed ID: 2073771
[TBL] [Abstract][Full Text] [Related]
5. The cardiovascular and hemodynamic effects of erythropoietin in chronic renal failure.
Singh NP; Chandrashekhar ; Nair M; Anuradha S; Kohli R; Agarwal SK
J Assoc Physicians India; 2000 Mar; 48(3):301-6. PubMed ID: 11229114
[TBL] [Abstract][Full Text] [Related]
6. Haemodynamic changes and exercise tolerance in dialysis patients treated with erythropoietin.
Jurić M; Rupcić V; Topuzović N; Jakić M; Brlosić R; Rusić A; Karner I; Stipanić S; Kes P
Nephrol Dial Transplant; 1995; 10(8):1398-404. PubMed ID: 8538932
[TBL] [Abstract][Full Text] [Related]
7. Echocardiographic evaluation in long-term continuous ambulatory peritoneal dialysis compared with the hemodialysis patients.
Takeda K; Nakamoto M; Baba M; Tanaka T; Yasunaga C; Nishihara G; Matsuo K; Urabe M
Clin Nephrol; 1998 May; 49(5):308-12. PubMed ID: 9617495
[TBL] [Abstract][Full Text] [Related]
8. Echocardiographic findings in patients on maintenance hemodialysis substituted with recombinant human erythropoietin.
Löw I; Grützmacher P; Bergmann M; Schoeppe W
Clin Nephrol; 1989 Jan; 31(1):26-30. PubMed ID: 2521587
[TBL] [Abstract][Full Text] [Related]
9. Influence of recombinant human erythropoietin treatment on cortisol responses to insulin-induced hypoglycemia in CAPD patients.
Díez JJ; Iglesias P; Sastre J; Gómez-Pan A; Selgas R; Romero JR; Méndez J
Adv Perit Dial; 1993; 9():336-41. PubMed ID: 8105958
[TBL] [Abstract][Full Text] [Related]
10. Progression of left ventricular hypertrophy in end-stage renal disease treated by continuous ambulatory peritoneal dialysis depends on hypertension and hypercirculation.
Hüting J; Alpert MA
Clin Cardiol; 1992 Mar; 15(3):190-6. PubMed ID: 1532353
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms of hypertension induced by erythropoietin in patients on hemodialysis.
Yamakado M; Umezu M; Nagano M; Tagawa H
Clin Invest Med; 1991 Dec; 14(6):623-9. PubMed ID: 1794212
[TBL] [Abstract][Full Text] [Related]
12. Erythropoietin associated hypertension among pediatric dialysis patients.
Komatsu Y; Ito K
Adv Perit Dial; 1992; 8():448-52. PubMed ID: 1361845
[TBL] [Abstract][Full Text] [Related]
13. What happens after conversion of treatment to continuous ambulatory peritoneal dialysis from hemodialysis?
Sezer S; Ozdemir N; Arat Z; Güz G; Sengül S; Akman B; Haberal A; Turan M; Haberal M
Adv Perit Dial; 2000; 16():177-81. PubMed ID: 11045288
[TBL] [Abstract][Full Text] [Related]
14. Peritoneal dialysis efficiency in CAPD patients in treatment with rHuEPO.
Vega N; Fernandez A; Hortal L; Macias M; Rodriguez JC; Plaza C; Perdomo M; Vega R; Palop L
Adv Perit Dial; 1992; 8():467-70. PubMed ID: 1361850
[TBL] [Abstract][Full Text] [Related]
15. Cardiovascular hemodynamic effects of correction of anemia of chronic renal failure with recombinant-human erythropoietin.
Schwartz AB; Prior JE; Mintz GS; Kim KE; Kahn SB
Transplant Proc; 1991 Apr; 23(2):1827-30. PubMed ID: 2053168
[TBL] [Abstract][Full Text] [Related]
16. Once weekly versus twice weekly subcutaneous administration of recombinant human erythropoietin in patients on continuous ambulatory peritoneal dialysis.
Lui SF; Law CB; Ting SM; Li P; Lai KN
Clin Nephrol; 1991 Nov; 36(5):246-51. PubMed ID: 1752075
[TBL] [Abstract][Full Text] [Related]
17. Improved response to erythropoietin in peritoneal dialysis patients as compared to hemodialysis patients: role of iron deficiency.
Raja R; Bloom E; Johnson R; Goldstein M
Adv Perit Dial; 1994; 10():135-8. PubMed ID: 7999811
[TBL] [Abstract][Full Text] [Related]
18. Hemodynamic and volume changes by recombinant human erythropoietin (rHuEPO) in the treatment of anemic hemodialysis patients.
Hori K; Onoyama K; Iseki K; Fujimi S; Fujishima M
Clin Nephrol; 1990 Jun; 33(6):293-8. PubMed ID: 2376091
[TBL] [Abstract][Full Text] [Related]
19. [Effect of defibrillation on hemodynamics during cardioverter defibrillator implantation].
Hayashi K
J Cardiol; 1999 Jul; 34(1):25-34. PubMed ID: 10422623
[TBL] [Abstract][Full Text] [Related]
20. Correction of anemia in patients on continuous ambulatory peritoneal dialysis with subcutaneous recombinant erythropoietin twice a week: a long-term study.
Cheng IK; Cy C; Chan MK; Yu L; Fang GX; Wei D
Clin Nephrol; 1991 May; 35(5):207-12. PubMed ID: 1855328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
